SBI Life Insurance Q1 Results: Net profit rises 22% YoY to ₹725 crore
SBI Life Insurance posted a 22% YoY net profit rise to ₹724.93 crore in Q1FY26, aided by a rebound in investment income and 17% premium growth. Embedded value hit ₹85,290 crore, solvency ratio improved to 1.96, and IRDAI granted an Ind AS adoption deferral to FY2027-28.

*this image is generated using AI for illustrative purposes only.
SBI Life Insurance reported a 22% year-on-year increase in net profit after tax to ₹724.93 crore for the quarter ended June 30, 2026 (Q1FY26), reflecting robust premium growth and favorable investment income. The Mumbai-based life insurer also disclosed an embedded value of ₹85,290 crore as of June 30, 2026, underscoring its long-term value creation amidst a competitive market landscape.
The Board of Directors approved the unaudited financial results on July 24, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Joint statutory auditors K S Aiyar & Co and J Singh & Associates issued limited review reports with unmodified opinions. The trading window for designated persons re-opened on July 27, 2026.
Financial Performance
Net premium income rose 17% year-on-year to ₹20,078.21 crore, supported by growth in first-year premiums to ₹4,954.93 crore from ₹3,539.47 crore in Q1FY25. Renewal premiums increased to ₹12,381.79 crore, while single premiums stood at ₹3,952.93 crore. Investment income surged to ₹25,977.02 crore, a significant improvement from a negative ₹23,938.72 crore in the previous quarter, contributing materially to the bottom line.
| Metric | Q1FY26 (₹ crore) | Q1FY25 (₹ crore) | Change |
|---|---|---|---|
| Net Premium Income | 20,078.21 | 17,178.50 | +17% |
| Net Profit After Tax | 724.93 | 594.37 | +22% |
| Earnings Per Share | ₹7.23 | ₹5.93 | +22% |
Expenses of management remained stable at ₹2,565.02 crore compared to ₹1,915.17 crore in the prior year period, though operational efficiency metrics require monitoring given the scale of operations. The surplus transferred to shareholders’ account was ₹457.78 crore.
Key Ratios and Metrics
The insurer’s solvency ratio improved to 1.96 from 1.90 in March 2026, maintaining a comfortable buffer above regulatory requirements. The expense management ratio stood at 12.05%, up from 10.75% in Q1FY25, indicating slight pressure on cost efficiency relative to premium volume. Persistency ratios showed mixed trends, with the 13th-month premium basis persistency at 84.35% compared to 84.24% in the same quarter last year.
What the Numbers Show
A notable divergence exists between the top-line premium growth and the volatility in investment income. While net premiums grew steadily by 17%, investment income swung from a negative position in Q4FY26 to a positive ₹25,977.02 crore in Q1FY26. This suggests that quarterly profitability remains sensitive to market movements and unrealized gains/losses, rather than being driven purely by underwriting performance. Investors should monitor whether this investment tailwind is sustainable or cyclical.
Regulatory and Strategic Updates
The Insurance Regulatory and Development Authority of India (IRDAI) granted SBI Life a one-year forbearance for adopting Indian Accounting Standards (Ind AS), deferring implementation to FY2027-28. Consequently, these results are prepared under Indian GAAP. Additionally, the Securities Appellate Tribunal dismissed Sahara India Life Insurance Company Limited’s appeal against the IRDAI order directing the transfer of its business to SBI Life. The company will maintain separate books for the acquired portfolio during FY2026-27, with full integration reflected from April 1, 2027.
Historical Stock Returns for SBI Life Insurance
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.28% | +2.00% | +4.05% | -7.19% | +2.71% | +76.93% |
How will the full integration of the Sahara India Life portfolio starting April 2027 impact SBI Life's expense ratios and persistency metrics?
What is the sustainability of the current investment income surge given the historical volatility between Q4FY26 and Q1FY26?
How might the deferred adoption of Ind AS until FY2027-28 affect the comparability of SBI Life's financials with peers during this transition period?


































